Open Journal Systems

Advances in Gene Therapy for Human Genetic Diseases Based on Crispr/Cas9 Gene Editing Technology

Delia Gaskell1, Mosleh Abualhaj2

Article ID: 873
Vol 2, Issue 1, , Article identifier:

VIEWS - 210 (Abstract) 114 (PDF)


The CRISPR/Cas9 system provides a powerful technique for targeted gene editing. Using sequence-specific sgRNA guidance, the CRISPR/Cas9 system can accurately introduce double-stranded incisions into the exact location of the target DNA. At present, a large number of CRISSR/Cas9 gene editing studies involving multiple species in vivo and in vitro have fully demonstrated the tremendous potential of this technology, which brings hope for disease treatment research and clinical application based on this technology. This review will summarize recent advances in the use of CRISPR/Cas9 gene editing techniques in the treatment of human genetic diseases. Progress in pre clinical research.

Full Text:


(210 Abstract Views, 114 PDF Downloads)


  • There are currently no refbacks.

Copyright (c) 2018 Delia Gaskell

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.